Christian Hopfer
Concepts (402)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Substance-Related Disorders | 36 | 2023 | 947 | 3.980 |
Why?
| Marijuana Abuse | 21 | 2024 | 212 | 3.810 |
Why?
| Cannabis | 12 | 2024 | 384 | 3.280 |
Why?
| Conduct Disorder | 16 | 2023 | 193 | 2.230 |
Why?
| Marijuana Use | 8 | 2024 | 167 | 1.830 |
Why?
| Adolescent Behavior | 16 | 2020 | 489 | 1.570 |
Why?
| Alcohol Drinking | 15 | 2024 | 651 | 1.500 |
Why?
| Marijuana Smoking | 9 | 2022 | 224 | 1.460 |
Why?
| Alcoholism | 18 | 2023 | 713 | 1.300 |
Why?
| Social Environment | 10 | 2014 | 283 | 1.230 |
Why?
| Adolescent | 91 | 2024 | 17837 | 1.210 |
Why?
| Tobacco Use Disorder | 11 | 2020 | 234 | 1.190 |
Why?
| Polymorphism, Single Nucleotide | 21 | 2022 | 1879 | 1.160 |
Why?
| Antisocial Personality Disorder | 15 | 2018 | 156 | 1.130 |
Why?
| Genetic Predisposition to Disease | 16 | 2022 | 2085 | 1.050 |
Why?
| Twins | 9 | 2024 | 240 | 0.860 |
Why?
| Medical Marijuana | 3 | 2020 | 97 | 0.830 |
Why?
| Siblings | 12 | 2020 | 221 | 0.820 |
Why?
| Smoking | 16 | 2019 | 1381 | 0.780 |
Why?
| Analgesics, Opioid | 6 | 2020 | 771 | 0.780 |
Why?
| Genome-Wide Association Study | 14 | 2022 | 1177 | 0.760 |
Why?
| Young Adult | 37 | 2023 | 10465 | 0.760 |
Why?
| Risk-Taking | 7 | 2019 | 333 | 0.750 |
Why?
| Dronabinol | 2 | 2020 | 118 | 0.740 |
Why?
| Female | 93 | 2023 | 59488 | 0.740 |
Why?
| Male | 92 | 2023 | 55579 | 0.730 |
Why?
| Legislation, Drug | 4 | 2023 | 78 | 0.720 |
Why?
| Humans | 122 | 2024 | 114654 | 0.720 |
Why?
| Opioid-Related Disorders | 5 | 2021 | 413 | 0.710 |
Why?
| Colorado | 23 | 2022 | 4099 | 0.700 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 10 | 2018 | 230 | 0.700 |
Why?
| Problem Behavior | 2 | 2018 | 86 | 0.690 |
Why?
| Cannabinol | 1 | 2019 | 2 | 0.650 |
Why?
| Adult | 57 | 2024 | 30542 | 0.650 |
Why?
| Diseases in Twins | 4 | 2014 | 174 | 0.640 |
Why?
| Hallucinogens | 1 | 2020 | 73 | 0.630 |
Why?
| Homeless Youth | 3 | 2008 | 15 | 0.620 |
Why?
| Mental Disorders | 8 | 2021 | 892 | 0.620 |
Why?
| Longitudinal Studies | 25 | 2024 | 2387 | 0.600 |
Why?
| Criminals | 1 | 2018 | 29 | 0.600 |
Why?
| Substance Abuse, Intravenous | 3 | 2016 | 99 | 0.590 |
Why?
| Colitis, Ulcerative | 1 | 2019 | 105 | 0.590 |
Why?
| Sexual Behavior | 5 | 2019 | 440 | 0.580 |
Why?
| Prescription Drug Misuse | 1 | 2017 | 38 | 0.570 |
Why?
| Cigarette Smoking | 1 | 2018 | 72 | 0.570 |
Why?
| Receptors, Nicotinic | 7 | 2016 | 274 | 0.560 |
Why?
| Prevalence | 11 | 2022 | 2250 | 0.550 |
Why?
| Genetic Linkage | 3 | 2008 | 294 | 0.530 |
Why?
| Prescription Drug Diversion | 1 | 2016 | 12 | 0.520 |
Why?
| Crohn Disease | 1 | 2019 | 196 | 0.510 |
Why?
| Genotype | 15 | 2019 | 1760 | 0.490 |
Why?
| Motivation | 2 | 2018 | 494 | 0.480 |
Why?
| Body Mass Index | 3 | 2018 | 1958 | 0.470 |
Why?
| Accidents, Traffic | 2 | 2018 | 170 | 0.450 |
Why?
| Inflammatory Bowel Diseases | 1 | 2018 | 284 | 0.450 |
Why?
| Receptors, Dopamine D2 | 4 | 2007 | 86 | 0.440 |
Why?
| Family Health | 1 | 2014 | 193 | 0.420 |
Why?
| Polymorphism, Genetic | 4 | 2016 | 610 | 0.410 |
Why?
| Genetic Variation | 5 | 2022 | 870 | 0.400 |
Why?
| Heroin Dependence | 2 | 2003 | 22 | 0.390 |
Why?
| Phenotype | 14 | 2020 | 2796 | 0.360 |
Why?
| Prospective Studies | 9 | 2020 | 6217 | 0.350 |
Why?
| Child Abuse | 6 | 2021 | 456 | 0.350 |
Why?
| Urban Population | 2 | 2012 | 397 | 0.350 |
Why?
| Substance Abuse Detection | 2 | 2020 | 62 | 0.340 |
Why?
| Surveys and Questionnaires | 12 | 2019 | 4622 | 0.340 |
Why?
| United States | 17 | 2022 | 12179 | 0.340 |
Why?
| Impulsive Behavior | 4 | 2017 | 113 | 0.330 |
Why?
| Biological Specimen Banks | 4 | 2019 | 94 | 0.330 |
Why?
| Nurses, Community Health | 2 | 2019 | 28 | 0.330 |
Why?
| Substance Withdrawal Syndrome | 2 | 2019 | 159 | 0.320 |
Why?
| United Kingdom | 3 | 2019 | 226 | 0.320 |
Why?
| Prenatal Care | 3 | 2019 | 253 | 0.320 |
Why?
| Comorbidity | 8 | 2016 | 1448 | 0.320 |
Why?
| Criminal Behavior | 2 | 2018 | 6 | 0.310 |
Why?
| Haplotypes | 5 | 2009 | 448 | 0.310 |
Why?
| Attention Deficit Disorder with Hyperactivity | 5 | 2022 | 364 | 0.310 |
Why?
| House Calls | 2 | 2019 | 115 | 0.310 |
Why?
| Cognition | 4 | 2020 | 989 | 0.310 |
Why?
| Sex Factors | 10 | 2017 | 1715 | 0.300 |
Why?
| Adolescent Development | 2 | 2019 | 83 | 0.290 |
Why?
| Genetic Association Studies | 4 | 2021 | 339 | 0.290 |
Why?
| Case-Control Studies | 10 | 2019 | 3003 | 0.290 |
Why?
| Health Surveys | 5 | 2012 | 443 | 0.280 |
Why?
| Receptors, Cannabinoid | 1 | 2006 | 13 | 0.280 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2006 | 43 | 0.280 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2006 | 49 | 0.280 |
Why?
| Multifactorial Inheritance | 3 | 2022 | 122 | 0.280 |
Why?
| Cross-Sectional Studies | 8 | 2018 | 4407 | 0.280 |
Why?
| Analgesics | 2 | 2020 | 158 | 0.270 |
Why?
| Home Care Services | 2 | 2019 | 222 | 0.270 |
Why?
| Tandem Mass Spectrometry | 2 | 2020 | 411 | 0.270 |
Why?
| Mothers | 3 | 2019 | 651 | 0.270 |
Why?
| Multigene Family | 3 | 2013 | 190 | 0.270 |
Why?
| Drug Prescriptions | 2 | 2018 | 239 | 0.270 |
Why?
| Registries | 1 | 2014 | 1767 | 0.260 |
Why?
| Homosexuality | 1 | 2006 | 16 | 0.260 |
Why?
| Bisexuality | 1 | 2006 | 17 | 0.260 |
Why?
| Receptors, Dopamine D1 | 1 | 2006 | 25 | 0.260 |
Why?
| Tobacco Use | 2 | 2024 | 60 | 0.250 |
Why?
| Juvenile Delinquency | 4 | 2018 | 103 | 0.250 |
Why?
| Aggression | 4 | 2022 | 183 | 0.250 |
Why?
| Research Subjects | 2 | 2015 | 40 | 0.240 |
Why?
| Genomics | 3 | 2020 | 635 | 0.240 |
Why?
| Obesity | 1 | 2017 | 2508 | 0.240 |
Why?
| Linkage Disequilibrium | 7 | 2021 | 245 | 0.230 |
Why?
| Substance Abuse Treatment Centers | 3 | 2012 | 42 | 0.230 |
Why?
| Genome | 1 | 2006 | 271 | 0.230 |
Why?
| Age of Onset | 5 | 2018 | 446 | 0.230 |
Why?
| Child Behavior Disorders | 3 | 2011 | 131 | 0.230 |
Why?
| Internationality | 2 | 2022 | 143 | 0.220 |
Why?
| Alleles | 8 | 2018 | 789 | 0.220 |
Why?
| Interview, Psychological | 4 | 2013 | 86 | 0.220 |
Why?
| Child | 22 | 2022 | 18407 | 0.220 |
Why?
| Genetic Loci | 3 | 2022 | 262 | 0.220 |
Why?
| Gene Frequency | 6 | 2016 | 477 | 0.220 |
Why?
| Adoption | 1 | 2003 | 38 | 0.210 |
Why?
| Heroin | 1 | 2003 | 23 | 0.210 |
Why?
| Narcotics | 1 | 2003 | 44 | 0.210 |
Why?
| Nerve Tissue Proteins | 5 | 2013 | 529 | 0.210 |
Why?
| Models, Genetic | 6 | 2010 | 562 | 0.210 |
Why?
| Incidence | 4 | 2018 | 2312 | 0.200 |
Why?
| Risk Factors | 11 | 2022 | 8631 | 0.200 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 2 | 2016 | 72 | 0.200 |
Why?
| Age Factors | 6 | 2014 | 2894 | 0.190 |
Why?
| Public Health | 1 | 2006 | 433 | 0.190 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 56 | 0.180 |
Why?
| Cannabinoid Receptor Agonists | 1 | 2020 | 30 | 0.180 |
Why?
| Depression | 3 | 2022 | 1134 | 0.180 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 119 | 0.170 |
Why?
| Twins, Monozygotic | 4 | 2010 | 210 | 0.170 |
Why?
| Pain, Postoperative | 2 | 2019 | 191 | 0.170 |
Why?
| Autistic Disorder | 1 | 2022 | 162 | 0.170 |
Why?
| Monoamine Oxidase | 2 | 2013 | 27 | 0.170 |
Why?
| Health Risk Behaviors | 1 | 2019 | 13 | 0.170 |
Why?
| Nausea | 1 | 2020 | 101 | 0.170 |
Why?
| Maternal Health | 1 | 2019 | 42 | 0.170 |
Why?
| HIV Infections | 1 | 2013 | 2469 | 0.160 |
Why?
| Behavior, Addictive | 1 | 2020 | 81 | 0.160 |
Why?
| Middle Aged | 12 | 2023 | 26732 | 0.160 |
Why?
| Physician Incentive Plans | 1 | 2018 | 6 | 0.160 |
Why?
| Minisatellite Repeats | 1 | 2019 | 38 | 0.160 |
Why?
| Multimodal Imaging | 1 | 2019 | 88 | 0.160 |
Why?
| Pregnancy | 5 | 2022 | 5517 | 0.160 |
Why?
| Expressed Emotion | 1 | 2018 | 17 | 0.160 |
Why?
| Feeding and Eating Disorders | 1 | 2020 | 103 | 0.160 |
Why?
| Mortality, Premature | 1 | 2018 | 11 | 0.160 |
Why?
| Calcium-Transporting ATPases | 1 | 2018 | 34 | 0.160 |
Why?
| Chromatography, Liquid | 1 | 2020 | 347 | 0.160 |
Why?
| Digestive System Surgical Procedures | 1 | 2019 | 91 | 0.150 |
Why?
| Cannabinoids | 2 | 2017 | 115 | 0.150 |
Why?
| Biomedical Research | 2 | 2014 | 585 | 0.150 |
Why?
| Suicide | 2 | 2021 | 506 | 0.150 |
Why?
| Infant, Newborn | 4 | 2020 | 5044 | 0.150 |
Why?
| Analgesics, Non-Narcotic | 1 | 2019 | 120 | 0.140 |
Why?
| Urine | 1 | 2017 | 54 | 0.140 |
Why?
| Receptors, Opioid, mu | 2 | 2015 | 52 | 0.140 |
Why?
| Bioethics | 1 | 2017 | 13 | 0.140 |
Why?
| Neuropsychological Tests | 2 | 2020 | 927 | 0.140 |
Why?
| Unsafe Sex | 2 | 2016 | 58 | 0.140 |
Why?
| Physicians, Family | 1 | 2018 | 201 | 0.140 |
Why?
| Counseling | 1 | 2020 | 342 | 0.140 |
Why?
| Brain | 2 | 2019 | 2371 | 0.140 |
Why?
| Depressive Disorder, Major | 2 | 2020 | 301 | 0.140 |
Why?
| Administration, Oral | 1 | 2019 | 728 | 0.140 |
Why?
| Mental Health | 1 | 2022 | 562 | 0.140 |
Why?
| Lipids | 1 | 2020 | 580 | 0.130 |
Why?
| Gene-Environment Interaction | 2 | 2020 | 183 | 0.130 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2016 | 34 | 0.130 |
Why?
| Self Report | 2 | 2018 | 696 | 0.130 |
Why?
| Patient Admission | 2 | 2012 | 176 | 0.130 |
Why?
| Brain Mapping | 1 | 2019 | 524 | 0.130 |
Why?
| Drug Storage | 1 | 2016 | 58 | 0.130 |
Why?
| Interviews as Topic | 3 | 2007 | 582 | 0.130 |
Why?
| Mental Competency | 1 | 2015 | 26 | 0.130 |
Why?
| Plasma | 1 | 2017 | 211 | 0.130 |
Why?
| Surgical Procedures, Operative | 1 | 2018 | 207 | 0.130 |
Why?
| Drug Overdose | 2 | 2018 | 292 | 0.120 |
Why?
| Image Processing, Computer-Assisted | 1 | 2019 | 683 | 0.120 |
Why?
| Neuroimaging | 1 | 2017 | 249 | 0.120 |
Why?
| Life Change Events | 1 | 2016 | 135 | 0.120 |
Why?
| Exploratory Behavior | 2 | 2013 | 82 | 0.120 |
Why?
| Pregnancy Complications | 1 | 2019 | 429 | 0.120 |
Why?
| Patient Satisfaction | 1 | 2018 | 578 | 0.120 |
Why?
| Informed Consent | 1 | 2015 | 161 | 0.120 |
Why?
| Automobile Driving | 1 | 2016 | 128 | 0.120 |
Why?
| Cohort Studies | 6 | 2021 | 4895 | 0.120 |
Why?
| Proteomics | 1 | 2020 | 836 | 0.120 |
Why?
| Twins, Dizygotic | 3 | 2010 | 182 | 0.120 |
Why?
| Practice Patterns, Physicians' | 3 | 2019 | 1177 | 0.120 |
Why?
| Medicine | 1 | 2016 | 102 | 0.120 |
Why?
| Time Factors | 3 | 2019 | 6115 | 0.110 |
Why?
| Aged | 5 | 2018 | 19068 | 0.110 |
Why?
| Netherlands | 1 | 2014 | 64 | 0.110 |
Why?
| Genetic Testing | 1 | 2016 | 379 | 0.110 |
Why?
| Regression Analysis | 3 | 2019 | 944 | 0.110 |
Why?
| Receptors, GABA-A | 1 | 2014 | 82 | 0.110 |
Why?
| Emotions | 2 | 2021 | 472 | 0.110 |
Why?
| Conflict of Interest | 1 | 2014 | 119 | 0.110 |
Why?
| Temperament | 1 | 2013 | 46 | 0.100 |
Why?
| Patient Safety | 1 | 2016 | 277 | 0.100 |
Why?
| Condoms | 1 | 2013 | 113 | 0.100 |
Why?
| Severity of Illness Index | 2 | 2019 | 2537 | 0.100 |
Why?
| Socioeconomic Factors | 2 | 2013 | 1078 | 0.100 |
Why?
| Family Conflict | 1 | 2012 | 36 | 0.100 |
Why?
| Receptors, Oxytocin | 1 | 2012 | 23 | 0.100 |
Why?
| Sexual Partners | 1 | 2013 | 161 | 0.100 |
Why?
| Educational Status | 1 | 2013 | 412 | 0.100 |
Why?
| Multivariate Analysis | 2 | 2012 | 1430 | 0.100 |
Why?
| Family Relations | 1 | 2012 | 85 | 0.100 |
Why?
| Ethanol | 2 | 2012 | 538 | 0.090 |
Why?
| Psychometrics | 3 | 2009 | 608 | 0.090 |
Why?
| Logistic Models | 4 | 2019 | 1840 | 0.090 |
Why?
| Hospitalization | 1 | 2019 | 1750 | 0.090 |
Why?
| Dizziness | 1 | 2010 | 70 | 0.090 |
Why?
| Pentachlorophenol | 1 | 1990 | 22 | 0.090 |
Why?
| Biomarkers | 1 | 2020 | 3408 | 0.090 |
Why?
| Magnetic Resonance Imaging | 2 | 2019 | 3044 | 0.090 |
Why?
| Models, Statistical | 2 | 2010 | 599 | 0.080 |
Why?
| Suicidal Ideation | 3 | 2021 | 401 | 0.080 |
Why?
| Sample Size | 2 | 2022 | 112 | 0.080 |
Why?
| Models, Theoretical | 1 | 2013 | 515 | 0.080 |
Why?
| Receptor, Cannabinoid, CB1 | 1 | 2009 | 28 | 0.080 |
Why?
| Genetic Markers | 2 | 2007 | 320 | 0.080 |
Why?
| Retrospective Studies | 8 | 2021 | 12544 | 0.080 |
Why?
| Primary Health Care | 1 | 2018 | 1512 | 0.080 |
Why?
| Taq Polymerase | 2 | 2006 | 10 | 0.080 |
Why?
| Emergency Service, Hospital | 1 | 2019 | 1815 | 0.080 |
Why?
| Child Abuse, Sexual | 1 | 2009 | 81 | 0.080 |
Why?
| Stress, Psychological | 1 | 2016 | 944 | 0.080 |
Why?
| Quality of Life | 1 | 2019 | 2353 | 0.080 |
Why?
| Environment | 4 | 2012 | 332 | 0.070 |
Why?
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 9 | 0.070 |
Why?
| Methylphenidate | 2 | 2004 | 36 | 0.070 |
Why?
| Family | 4 | 2016 | 589 | 0.070 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 16 | 0.070 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2007 | 65 | 0.070 |
Why?
| Statistics as Topic | 1 | 2008 | 292 | 0.070 |
Why?
| Risk | 2 | 2020 | 812 | 0.070 |
Why?
| Schizophrenia | 2 | 2022 | 414 | 0.070 |
Why?
| 3' Untranslated Regions | 1 | 2007 | 129 | 0.070 |
Why?
| Microsatellite Repeats | 1 | 2006 | 136 | 0.070 |
Why?
| Child of Impaired Parents | 1 | 2006 | 40 | 0.070 |
Why?
| Fathers | 1 | 2006 | 45 | 0.070 |
Why?
| Cheek | 1 | 2006 | 16 | 0.070 |
Why?
| Poverty | 2 | 2019 | 442 | 0.070 |
Why?
| Lysergic Acid Diethylamide | 1 | 2006 | 2 | 0.070 |
Why?
| Central Nervous System Stimulants | 2 | 2004 | 139 | 0.070 |
Why?
| Social Facilitation | 1 | 2006 | 10 | 0.070 |
Why?
| Sodium Oxybate | 1 | 2006 | 4 | 0.070 |
Why?
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2006 | 10 | 0.070 |
Why?
| Alcohol-Related Disorders | 1 | 2007 | 113 | 0.070 |
Why?
| Parents | 2 | 2004 | 1186 | 0.060 |
Why?
| Genetics, Population | 1 | 2007 | 188 | 0.060 |
Why?
| Parenting | 1 | 2009 | 252 | 0.060 |
Why?
| Protein Kinase C | 1 | 2007 | 273 | 0.060 |
Why?
| Religion | 1 | 2006 | 64 | 0.060 |
Why?
| Methamphetamine | 1 | 2006 | 51 | 0.060 |
Why?
| Suicide, Attempted | 1 | 2008 | 317 | 0.060 |
Why?
| Beta Rhythm | 1 | 2004 | 10 | 0.060 |
Why?
| Universities | 1 | 2007 | 340 | 0.060 |
Why?
| Ketamine | 1 | 2006 | 92 | 0.060 |
Why?
| Pain Management | 2 | 2019 | 288 | 0.060 |
Why?
| Marriage | 1 | 2004 | 106 | 0.050 |
Why?
| Data Interpretation, Statistical | 3 | 2010 | 321 | 0.050 |
Why?
| Genome, Human | 2 | 2020 | 347 | 0.050 |
Why?
| Infant | 3 | 2021 | 7959 | 0.050 |
Why?
| Drug Tolerance | 1 | 2003 | 79 | 0.050 |
Why?
| Membrane Transport Proteins | 1 | 2003 | 138 | 0.050 |
Why?
| Loneliness | 1 | 2022 | 27 | 0.050 |
Why?
| Sensitivity and Specificity | 2 | 2021 | 1691 | 0.050 |
Why?
| Europe | 1 | 2022 | 334 | 0.050 |
Why?
| Predictive Value of Tests | 2 | 2021 | 1796 | 0.050 |
Why?
| Models, Psychological | 2 | 2016 | 297 | 0.050 |
Why?
| Electroencephalography | 1 | 2003 | 362 | 0.050 |
Why?
| Personality Assessment | 2 | 2013 | 77 | 0.050 |
Why?
| Calibration | 1 | 2021 | 125 | 0.050 |
Why?
| Membrane Glycoproteins | 1 | 2003 | 430 | 0.050 |
Why?
| Proportional Hazards Models | 2 | 2018 | 1075 | 0.050 |
Why?
| Follow-Up Studies | 2 | 2019 | 4411 | 0.050 |
Why?
| Bayes Theorem | 1 | 2021 | 329 | 0.040 |
Why?
| Polymerase Chain Reaction | 2 | 2014 | 993 | 0.040 |
Why?
| Bipolar Disorder | 1 | 2022 | 205 | 0.040 |
Why?
| Minnesota | 1 | 2020 | 134 | 0.040 |
Why?
| Interrupted Time Series Analysis | 1 | 2019 | 44 | 0.040 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 83 | 0.040 |
Why?
| Drug Utilization Review | 1 | 2019 | 57 | 0.040 |
Why?
| Dangerous Behavior | 1 | 2018 | 20 | 0.040 |
Why?
| Infant, Small for Gestational Age | 1 | 2019 | 76 | 0.040 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2019 | 133 | 0.040 |
Why?
| Electronic Mail | 1 | 2018 | 54 | 0.040 |
Why?
| Child, Preschool | 2 | 2022 | 9111 | 0.040 |
Why?
| Safety-net Providers | 1 | 2019 | 95 | 0.040 |
Why?
| Factor Analysis, Statistical | 2 | 2010 | 257 | 0.040 |
Why?
| Treatment Outcome | 2 | 2019 | 9087 | 0.040 |
Why?
| Tobacco Products | 1 | 2019 | 98 | 0.040 |
Why?
| Statistics, Nonparametric | 2 | 2012 | 385 | 0.040 |
Why?
| Atmospheric Pressure | 1 | 2017 | 18 | 0.040 |
Why?
| Preoperative Period | 1 | 2018 | 103 | 0.040 |
Why?
| Epidemics | 1 | 2018 | 69 | 0.040 |
Why?
| Limit of Detection | 1 | 2017 | 53 | 0.040 |
Why?
| Executive Function | 1 | 2021 | 380 | 0.040 |
Why?
| Transcriptome | 1 | 2022 | 725 | 0.040 |
Why?
| Pregnancy Outcome | 1 | 2019 | 337 | 0.040 |
Why?
| Gene Expression | 2 | 2016 | 1421 | 0.040 |
Why?
| Postoperative Period | 1 | 2018 | 289 | 0.040 |
Why?
| Psychiatric Status Rating Scales | 2 | 2010 | 482 | 0.030 |
Why?
| Chromosome Mapping | 2 | 2008 | 487 | 0.030 |
Why?
| California | 1 | 2017 | 353 | 0.030 |
Why?
| Mortality | 1 | 2018 | 287 | 0.030 |
Why?
| Cause of Death | 1 | 2018 | 361 | 0.030 |
Why?
| Nicotine | 2 | 2010 | 265 | 0.030 |
Why?
| CD56 Antigen | 1 | 2016 | 34 | 0.030 |
Why?
| Violence | 1 | 2018 | 202 | 0.030 |
Why?
| Quality Control | 1 | 2016 | 144 | 0.030 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2017 | 470 | 0.030 |
Why?
| Sleep | 1 | 2021 | 631 | 0.030 |
Why?
| Anxiety | 1 | 2022 | 840 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2003 | 1394 | 0.030 |
Why?
| Potassium Channels | 1 | 2016 | 121 | 0.030 |
Why?
| Reward | 1 | 2017 | 211 | 0.030 |
Why?
| Thoracic Surgical Procedures | 1 | 2016 | 57 | 0.030 |
Why?
| Heterozygote | 1 | 2016 | 251 | 0.030 |
Why?
| Cell Adhesion Molecules | 1 | 2016 | 168 | 0.030 |
Why?
| Psychology, Adolescent | 1 | 2015 | 63 | 0.030 |
Why?
| Aging | 1 | 2004 | 1618 | 0.030 |
Why?
| Sexually Transmitted Diseases | 1 | 2016 | 155 | 0.030 |
Why?
| Likelihood Functions | 1 | 2015 | 126 | 0.030 |
Why?
| Demography | 1 | 2015 | 260 | 0.030 |
Why?
| Cesarean Section | 1 | 2016 | 169 | 0.030 |
Why?
| Disclosure | 1 | 2014 | 101 | 0.030 |
Why?
| Risk Assessment | 2 | 2015 | 2968 | 0.030 |
Why?
| Arsenites | 1 | 1993 | 4 | 0.030 |
Why?
| Arsenic Poisoning | 1 | 1993 | 7 | 0.030 |
Why?
| Databases, Factual | 1 | 2018 | 1125 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2016 | 410 | 0.030 |
Why?
| Chelating Agents | 1 | 1993 | 65 | 0.030 |
Why?
| Cotinine | 1 | 2013 | 69 | 0.030 |
Why?
| Arsenicals | 1 | 1993 | 24 | 0.030 |
Why?
| Gluconeogenesis | 1 | 1993 | 62 | 0.030 |
Why?
| Child Behavior | 2 | 2005 | 219 | 0.030 |
Why?
| Students | 1 | 2017 | 502 | 0.030 |
Why?
| Kidney Tubules | 1 | 1993 | 107 | 0.030 |
Why?
| Psychological Theory | 1 | 2013 | 94 | 0.030 |
Why?
| Privacy | 1 | 2012 | 28 | 0.030 |
Why?
| Probability | 1 | 2013 | 289 | 0.030 |
Why?
| Software | 1 | 2016 | 530 | 0.020 |
Why?
| Carrier Proteins | 1 | 2016 | 695 | 0.020 |
Why?
| Pedigree | 1 | 2013 | 460 | 0.020 |
Why?
| Disease Progression | 1 | 2018 | 2380 | 0.020 |
Why?
| Antidotes | 1 | 1993 | 135 | 0.020 |
Why?
| Attitude of Health Personnel | 1 | 2018 | 975 | 0.020 |
Why?
| Exercise | 1 | 2021 | 1644 | 0.020 |
Why?
| Reproducibility of Results | 2 | 2009 | 2762 | 0.020 |
Why?
| Prognosis | 1 | 2018 | 3327 | 0.020 |
Why?
| Pleasure | 1 | 2010 | 18 | 0.020 |
Why?
| Sensation | 1 | 2010 | 44 | 0.020 |
Why?
| Chromatography, Gas | 1 | 1990 | 27 | 0.020 |
Why?
| Membrane Proteins | 1 | 2016 | 1018 | 0.020 |
Why?
| Rats, Inbred Strains | 1 | 1990 | 362 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2012 | 381 | 0.020 |
Why?
| Patient Discharge | 1 | 2016 | 772 | 0.020 |
Why?
| Negotiating | 1 | 2009 | 27 | 0.020 |
Why?
| Psychological Tests | 1 | 2010 | 120 | 0.020 |
Why?
| Molecular Structure | 1 | 1990 | 434 | 0.020 |
Why?
| Epistasis, Genetic | 1 | 2009 | 67 | 0.020 |
Why?
| Personality Inventory | 1 | 2009 | 131 | 0.020 |
Why?
| Mouth Mucosa | 1 | 2007 | 79 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 923 | 0.020 |
Why?
| Parent-Child Relations | 1 | 2009 | 235 | 0.020 |
Why?
| Odds Ratio | 1 | 2009 | 953 | 0.020 |
Why?
| Analysis of Variance | 1 | 2009 | 1226 | 0.020 |
Why?
| Rats | 2 | 1993 | 4958 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 740 | 0.020 |
Why?
| Linear Models | 1 | 2007 | 768 | 0.020 |
Why?
| Confidence Intervals | 1 | 2006 | 305 | 0.020 |
Why?
| Reference Values | 1 | 2006 | 743 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 6345 | 0.020 |
Why?
| Research Design | 1 | 2009 | 928 | 0.010 |
Why?
| Frontal Lobe | 1 | 2004 | 141 | 0.010 |
Why?
| Schools | 1 | 2006 | 399 | 0.010 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2003 | 41 | 0.010 |
Why?
| Chi-Square Distribution | 1 | 2004 | 493 | 0.010 |
Why?
| Housing | 1 | 2004 | 114 | 0.010 |
Why?
| Family Characteristics | 1 | 2004 | 151 | 0.010 |
Why?
| Algorithms | 1 | 2008 | 1467 | 0.010 |
Why?
| Attention | 1 | 2004 | 393 | 0.010 |
Why?
| Transcription, Genetic | 1 | 2007 | 1313 | 0.010 |
Why?
| DNA | 1 | 2007 | 1352 | 0.010 |
Why?
| Cognition Disorders | 1 | 2003 | 476 | 0.010 |
Why?
| Double-Blind Method | 1 | 2003 | 1660 | 0.010 |
Why?
| Arsenates | 1 | 1993 | 1 | 0.010 |
Why?
| Unithiol | 1 | 1993 | 2 | 0.010 |
Why?
| Dimercaprol | 1 | 1993 | 6 | 0.010 |
Why?
| Succimer | 1 | 1993 | 4 | 0.010 |
Why?
| Arsenic | 1 | 1993 | 37 | 0.010 |
Why?
| Animals | 2 | 1993 | 31698 | 0.010 |
Why?
| Drug Evaluation, Preclinical | 1 | 1993 | 161 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 1993 | 396 | 0.010 |
Why?
| In Vitro Techniques | 1 | 1993 | 1016 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 1993 | 2218 | 0.000 |
Why?
| Mice | 1 | 1993 | 14863 | 0.000 |
Why?
|
|
Hopfer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|